Belpointe Asset Management LLC Invitae Corp Transaction History

Belpointe Asset Management LLC

  • $1.24 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$24.31 - $33.6 $164,870 - $227,875
-6,782 Closed
0 $0
Q2 2021

Aug 09, 2021
SELL
$26.09 - $40.4 $61,624 - $95,424
-2,362 Reduced 25.83%
6,782 $228,000
Q1 2021

May 14, 2021
BUY
$33.06 - $56.93 $36,762 - $63,306
1,112 Added 13.84%
9,144 $350,000
Q4 2020

Feb 16, 2021
BUY
$39.09 - $57.4 $97,255 - $142,811
2,488 Added 44.88%
8,032 $336,000
Q3 2020

Nov 13, 2020
BUY
$28.43 - $44.67 $157,615 - $247,650
5,544 New
5,544 $241,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email